Proactive Investors - Run By Investors For Investors

Andrew Left of Citron Research looking to create cannabis-fund, says Bloomberg

The fund would invest in Canadian-listed cannabis companies
Tilray symbol
Tilray is a Canadian cannabis company

Activist stock researcher Andrew Left of Citron Research is looking to create a cannabis-related fund to play both the long and short positions in the sector, a report by Bloomberg said.

Left, who is short on cannabis stocks such as Tiltary Inc (NASDAQ:TLRY) and Cronos Group Inc (NASDAQ:CRON), said the fund’s value would likely be in the hundreds of millions of dollars, the report said.

The fund would invest in Canadian-listed marijuana companies before expanding to US firms if they are able to list on US exchanges over a 24-month period.

READ: Are marijuana stocks too high for an investor tempted to join the party, or do they have room to run?

“It’s not the ninth inning, it’s the third inning because we’re only trading with Canadian companies. There’s so many private companies in the US that can’t go public in the US. Whether it’s going to be in two years depending on who our attorney general will be or in four years, it’s going to happen,” Left said in the report.

Cannabis-listed companies have turned into a hot market sector ahead of the legalization of cannabis in Canada in mid-October.

View full CRON profile View Profile

Cronos Group Inc Timeline

Related Articles

Scientist conducting work
Sun
CaPre, a potent form of Omega-3, has been shown to reduce triglycerides, but also lower 'bad cholesterol' levels, and raise 'good' ones
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
A double helix and a medical person
March 06 2019
Leronlimab, according to the company, is an antiviral agent candidate with fewer side effects, lower toxicity and less frequent doses than daily HIV therapies now in use
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use